Yelena Y Janjigian Selected Research

Yelena Y Janjigian Research Topics

Disease

76	Neoplasms (Cancer) 03/2024 - 04/2010
40	Adenocarcinoma 02/2024 - 04/2014
28	Stomach Neoplasms (Stomach Cancer) 03/2024 - 05/2011
7	Esophageal Neoplasms (Esophageal Cancer) 02/2024 - 01/2020
6	Disease Progression 12/2023 - 12/2012
6	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2010
5	Microsatellite Instability 01/2023 - 01/2018
4	Esophageal Squamous Cell Carcinoma 02/2024 - 12/2015
4	Lung Neoplasms (Lung Cancer) 09/2014 - 10/2011
3	Carcinoma (Carcinomatosis) 02/2024 - 01/2017
3	Pathologic Complete Response 06/2023 - 01/2016
3	Fatigue 11/2017 - 04/2010
3	Breast Neoplasms (Breast Cancer) 10/2016 - 11/2011
3	Adenocarcinoma of Lung 12/2012 - 03/2011
2	Nausea 12/2023 - 12/2023
2	Leukemia 01/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 11/2022
2	Carcinogenesis 11/2022 - 12/2018
2	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 02/2016
2	Exanthema (Rash) 11/2017 - 04/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017 - 12/2010
2	Colonic Neoplasms (Colon Cancer) 02/2016 - 04/2014
1	Pneumonia (Pneumonitis) 12/2023
1	Colitis 12/2023
1	Sepsis (Septicemia) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Residual Neoplasm 11/2023
1	Margins of Excision 11/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Atherosclerosis 01/2023
1	Obesity 11/2021

Drug/Important Bio-Agent (IBA)

16	Trastuzumab (Herceptin)FDA Link 12/2023 - 11/2013
15	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2011
13	Immune Checkpoint InhibitorsIBA 02/2024 - 07/2018
12	human ERBB2 proteinIBA 12/2023 - 11/2011
11	NivolumabIBA 02/2024 - 10/2018
10	pembrolizumabIBA 12/2023 - 07/2018
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
6	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 04/2014
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2017 - 03/2011
6	Gefitinib (Iressa)FDA Link 11/2017 - 03/2011
6	Tyrosine Kinase InhibitorsIBA 01/2015 - 03/2011
5	AfatinibIBA 01/2019 - 10/2012
4	zirconium-89-trastuzumabIBA 01/2023 - 06/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
4	Cetuximab (Erbitux)FDA Link 11/2017 - 04/2011
3	B7-H1 AntigenIBA 03/2024 - 10/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 06/2013
3	PlatinumIBA 12/2023 - 01/2011
3	Phosphotransferases (Kinase)IBA 01/2022 - 09/2014
3	IpilimumabIBA 01/2022 - 10/2018
3	RamucirumabIBA 01/2022 - 01/2016
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2015
3	EnzymesIBA 12/2019 - 02/2016
3	Bevacizumab (Avastin)FDA Link 12/2016 - 12/2010
2	regorafenibIBA 10/2023 - 01/2020
2	durvalumabIBA 01/2023 - 06/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 01/2011
2	NucleotidesIBA 01/2022 - 12/2019
2	Caveolin 1IBA 01/2022 - 12/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2018
2	Lovastatin (Mevacor)FDA LinkGeneric 11/2019 - 12/2018
2	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2015
2	Formaldehyde (Formol)FDA Link 01/2017 - 11/2011
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 08/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 05/2011
2	ParaffinIBA 01/2017 - 11/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2016 - 04/2014
2	Epidermal Growth Factor (EGF)IBA 10/2016 - 04/2014
2	Lapatinib (GW572016)FDA Link 02/2016 - 11/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 04/2014
2	RNA (Ribonucleic Acid)IBA 05/2011 - 05/2011
1	AlbuminsIBA 03/2024
1	Trinitrotoluene (TNT)IBA 06/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 12/2022
1	CarcinogensIBA 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	crenolanibIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CholesterolIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022

Therapy/Procedure

47	Therapeutics 12/2023 - 03/2011
38	Drug Therapy (Chemotherapy) 02/2024 - 12/2010
11	Neoadjuvant Therapy 02/2024 - 01/2018
9	Immunotherapy 02/2024 - 01/2016
6	Esophagectomy 11/2023 - 01/2018
6	Gastrectomy 11/2021 - 04/2015
5	Chemoradiotherapy 02/2024 - 01/2018
5	Induction Chemotherapy 01/2023 - 12/2015
3	Adjuvant Chemotherapy 12/2023 - 01/2019
2	Radiotherapy 01/2023 - 12/2010
1	Combination Drug Therapy (Combination Chemotherapy) 04/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Minimally Invasive Surgical Procedures 07/2021
1	Combined Modality Therapy 01/2021